Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cipla
QuintilesIMS
Farmers Insurance
Boehringer Ingelheim
Baxter
Cerilliant
Deloitte
Dow
Queensland Health

Generated: October 19, 2017

DrugPatentWatch Database Preview

PLIAGLIS Drug Profile

« Back to Dashboard

Which patents cover Pliaglis, and what generic Pliaglis alternatives are available?

Pliaglis is a drug marketed by Taro Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has seventeen patent family members in eleven countries.

The generic ingredient in PLIAGLIS is lidocaine; tetracaine. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.

Summary for Tradename: PLIAGLIS

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list9
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PLIAGLIS at DailyMed

Pharmacology for Tradename: PLIAGLIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharms
PLIAGLIS
lidocaine; tetracaine
CREAM;TOPICAL021717-001Jun 29, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PLIAGLIS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro Pharms
PLIAGLIS
lidocaine; tetracaine
CREAM;TOPICAL021717-001Jun 29, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PLIAGLIS

Country Document Number Estimated Expiration
Japan2012246315► Subscribe
Japan2007126462► Subscribe
Canada2386017► Subscribe
Portugal1244401► Subscribe
China100367927► Subscribe
European Patent Office1702597► Subscribe
Australia7719800► Subscribe
Denmark1244401► Subscribe
Japan2007217431► Subscribe
China101219108► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Accenture
Farmers Insurance
Moodys
Dow
Mallinckrodt
US Department of Justice
Chubb
Cantor Fitzgerald
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot